Who is sponsoring NCT00693654?

NCT00693654 is sponsored by Wake Forest University.

What drugs are being tested in NCT00693654?

Interventions: Sarna, Cetaphil.

What is the status of NCT00693654?

NCT00693654 is currently COMPLETED.

Last reviewed 2018-08-09 · How we verify

A Controlled Comparative Study of the Efficacy of SARNA Sensitive Lotion for Treatment of Uremic Pruritus in Adult Hemodialysis Patients

NCT00693654 Phase 4 COMPLETED Results posted

The purpose of this research study is to evaluate the efficacy of SARNA Sensitive Lotion in the treatment of uremic pruritus in adult hemodialysis patients in a double-blind Controlled comparative trial.

Details

Lead sponsor	Wake Forest University
Phase	Phase 4
Status	COMPLETED
Enrolment	28
Start date	2006-11
Completion	2008-10

Conditions

Pruritis

Interventions

Sarna
Cetaphil

Primary outcomes

Investigator Global Assessment — Disease severity assessed at baseline and 4 weeks, week 4 reported
Investigator's Global Assessment Disease Severity is based on the following scale: 0 = completely clear: except for possible residual hyper pigmentation 1. = almost clear: very significant clearance (about 90%) 2. = Marked improvement: significant improvement (about 75%) 3. = Moderate improvement: intermediate between slight and marked; representing about 50% improvements 4. = Slight improvement: some improvement (about 25%); however, significant disease remaining 5. = No change (moderate to severe disease) 6. = Worse

Countries

United States